Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
CDK12 和 CDK13 的双重抑制揭示了患者来源的卵巢癌类器官中可操作的脆弱性
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-023-02682-5
Cesari, Eleonora; Ciucci, Alessandra; Pieraccioli, Marco; Caggiano, Cinzia; Nero, Camilla; Bonvissuto, Davide; Sillano, Francesca; Buttarelli, Marianna; Piermattei, Alessia; Loverro, Matteo; Camarda, Floriana; Greco, Viviana; De Bonis, Maria; Minucci, Angelo; Gallo, Daniela; Urbani, Andrea; Vizzielli, Giuseppe; Scambia, Giovanni; Sette, Claudio
CDK1
肿瘤
肿瘤免疫
卵巢癌
CDK12
CDK13
3D/类器官